ARTBIO
PrivateLast Round
Series B
Jul 29, 2025
Total Funding Raised
$245M
Momentum Score
50 /100
Company Overview
ARTBIO is a radiopharmaceutical company that specializes in radioligand therapy to deliver targeted alpha or beta emitters for the treatment of cancer, enhancing therapeutic efficacy by disrupting cancer cell DNA and optimizing the treatment environment for medical practitioners.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTBIO Comps
Public and private peers based on sector, stage, and business model.
ARTBIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2025 | ||||
| Series A | Dec 7, 2023 | ||||
| Seed | Jun 21, 2023 |
ARTBIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Series B, Series A, Seed |
| B Capital Group | Series B |
| F-Prime Capital | Series A, Seed |
| Alexandria Venture Investments | Series B |
| F-Prime Capital | Series B |
| Radforsk | Seed |
| Sofinnova Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Lead program AB001 is in first-in-human trials.
- Jul 29, 2025
$132M round closed.
ARTBIO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARTBIO's valuation, stock price, and market status.